1
1Imagine a relay race where the baton gets passed smoothly from one runner to the next—no drops, no delays, no confusion. That’s exactly what Marken (part of UPS Healthcare Precision Logistics) just launched across the APAC region (Asia-Pacific): a single, connected logistics network that carries medicines and medical devices from the earliest clinical trials all the way to the patient’s doorstep.
Important Point
One Team. One Network. One Connected Journey.
This new integrated solution combines clinical, commercial, medical device, and patient-centric logistics under one roof—so healthcare companies don’t have to juggle multiple providers anymore.
Think of medicine delivery like a super-careful package delivery service, but with extra rules:
Before this launch, a drug company might need one company for clinical trials, another for commercial storage, another for medical devices, and yet another for patient home delivery. That’s like hiring four different moving companies to move one house—things get lost, slowed down, or confused.
Now, Marken + UPS Healthcare = One Team handling it all.
This integrated network brings together three specialized areas—each with its own "superpower":
Important Point
300,000+ square feet of new storage capacity added across three state-of-the-art facilities in Singapore—all GMP and GDP compliant. That’s roughly five football fields of high-tech medicine storage!
| For Healthcare Companies | For Patients |
|---|---|
| Faster time to market – no handoff delays between vendors | Quicker access to new treatments |
| One trusted partner – single point of contact, single contract | More reliable delivery – medicines arrive on time, at the right temperature |
| End-to-end visibility – track everything in one system | Home delivery options – clinical trial meds or specialty drugs brought to your door |
| Scalable across APAC – grow without switching providers | Consistent quality – same high standards everywhere |
"Healthcare companies are rethinking how they design and manage supply chains for the next wave of innovation… We have a regional network built for this complexity and pace, allowing us to move faster, coordinate more effectively and tailor solutions across APAC."
— Poh Meng, Vice President, APAC
This isn’t just about today’s medicines. It’s built for tomorrow’s breakthroughs:
The network is scalable, resilient, and precision-built—so as therapies get more complex, the supply chain keeps up.
Important Point
Whether you’re running a Phase I trial in Singapore, launching a commercial drug in Japan, or delivering a medical device to a patient’s home in Australia—one call, one team, one connected journey.
GMP = Good Manufacturing Practice (strict rules for making/storing medicines). GDP = Good Distribution Practice (strict rules for transporting/storing medicines safely). Together, they mean every step meets the highest global quality standards—so medicines stay safe and effective.
Cold chain = keeping temperature-sensitive medicines (like vaccines, biologics, cell therapies) at the exact required temperature from factory to patient. If the chain breaks—even for minutes—the medicine can be ruined. This network has end-to-end cold chain control.
Yes! That’s the whole point. The same facilities, same team, same systems handle early-phase clinical supplies and commercial drug distribution—so when your trial succeeds, you’re already set up for launch.
It’s the safe return, refurbishment, recycling, or disposal of used/expired devices. Think: a hospital returns a used surgical robot → Marken picks it up → it’s cleaned, repaired, or recycled responsibly. Full lifecycle management.
No. The solution is scalable—whether you’re a startup running your first APAC trial or a global company launching across 10 countries, the network flexes to your size and complexity.